XML 40 R57.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Narrative) (Details) (USD $)
In Millions, except Per Share data, unless otherwise specified
12 Months Ended 0 Months Ended 12 Months Ended
Dec. 31, 2011
years
Dec. 25, 2010
Dec. 26, 2009
Feb. 26, 2010
years
Feb. 26, 2010
PBG [Member]
Feb. 26, 2010
PAS [Member]
Dec. 31, 2011
Stock-Based Compensation [Member]
Dec. 31, 2011
Beginning in 2012 [Member]
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]                
Stock-based compensation expense $ 326 $ 299 $ 227          
Merger and integration costs included in stock-based compensation 13 53            
Restructuring charges 383           4  
Unvested acquisition-related grants   86            
Employee service share-based compensation, tax benefit from compensation expense 101 89 67          
Common stock, capital shares reserved for future issuance 136              
Stock option equity issuances, vested at acquisition       8.3        
RSU equity issuances, vested at acquisition       0.6        
Stock options, unvested       5.5        
RSUs, unvested       2.1        
Acquisition-related awards remaining vesting period, in years       3        
Stock option exercisable life (in years) 10              
Percent of equity awards granted to Senior Officers as stock options 50.00%              
Percent of equity awards granted to Senior Officers as performance-based RSUs 50.00%             60.00%
Percent of equity awards granted to Senior Officers as long-term cash awards               40.00%
Unrecognized compensation cost related to nonvested share-based compensation grants 436              
Weighted-average period for recognizing unrecognized compensation (in years) 2              
Total stock-based compensation expense $ 343 $ 352 $ 227          
Weighted-average grant price, stock options         $ 42.89 $ 31.72    
Weighted-average grant price, RSUs $ 63.87 [1] $ 65.01 $ 53.22   $ 62.30      
Stock options issued         13.4 0.4    
RSUs issued         2.7      
[1] Weighted-average intrinsic value at grant date.